0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Tolbutamide in Treatment of Multiple Sclerosis and Parkinsonism

Hubert C. Peltier, M.D.; Thomas J. Vecchio, M.D.
JAMA. 1961;176(2):167. doi:10.1001/jama.1961.03040150082024.
Text Size: A A A
Published online

ABSTRACT

To the Editor:—  Since tolbutamide has attained widespread use in the treatment of diabetes, there have been several reports of its use in unrelated disorders, including schizophrenia, acne, angina pectoris, intermittent claudication, paralysis agitans, and, most recently, multiple sclerosis. The possibility that the drug might be of value in these conditions was usually suggested initially by improvement in the condition of patients who had a combination of diabetes and one of the above diseases. However, it should be noted that therapy in all of these diseases has been notoriously difficult to evaluate in the past either because of their variable course, characterized by remissions and exacerbations or because of a pronounced placebo effect. Confirmatory reports have not been forthcoming, and other investigators working in several of the above areas have not been impressed by the value of the drug.The occasional value of serendipity in medical discoveries cannot be denied.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

* * SCHEDULED MAINTENANCE * *

Our websites may be periodically unavailable between midnight and 04:00 ET Thursday, July 10th, for regularly scheduled maintenance.

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();